Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus.
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
An outbreak of paralytic poliomyelitis occurred in the Dominican Republic (13 confirmed cases) and Haiti (8 confirmed cases, including 2 fatal cases) during 2000-2001. All but one of the patients were either unvaccinated or incompletely vaccinated children, and cases occurred in communities with very low (7 to 40%) rates of coverage with oral poliovirus vaccine (OPV). The outbreak was associated with the circulation of a derivative of the type 1 OPV strain, probably originating from a single OPV dose given in 1998-1999. The vaccine-derived poliovirus associated with the outbreak had biological properties indistinguishable from those of wild poliovirus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The first outbreak of cVDPV was identified in the Dominican Republic and Haiti between 2000 and 2001.”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [91]
In the citing paper
“In general, the VP1 sequences examined from cVDPV isolates differed from parental OPV strains by only 1–3.5%, suggesting that reversion to the attenuated phenotype of Sabin strains occurs with circulation times of 1–4 years [91,92,93,95,100].”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [91]
In the citing paper
“As with the other epidemics in Egypt and Hispaniola, VDPV circulated in a province of Madagascar with low OPV coverage (6,7).”
From Recombinant Vaccine–Derived Poliovirus in Madagascar (2003) · cites this paper as [7]
In the citing paper
“Most VDPV strains described as OPV/HEV-C recombinants were isolated in countries in which wild PVs have been eradicated”
From Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar (2007) · cites this paper as [12]
In the citing paper
“The cVDPV had recovered two of the most important biological properties of wild PV: the capacity to cause severe paralytic disease in humans and the capacity for extensive human-to-human transmission.”
From Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence (2011) · cites this paper as [83]
31 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Oberste, M. S., Maher, K., Kilpatrick, D. R., & Pallansch, M. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.1941-1948.1999 · Cited by 866
Self-citationStrebel, P. M., Sutter, R. W., Cochi, S. L., Biellik, R. J., Brink, E. W., Kew, O. M., Pallansch, M. A., Orenstein, W. A., & Hinman, A. R. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.568 · Cited by 337
Self-citationKawamura, N., Kohara, M., Abe, S., Komatsu, T., Tago, K., Arita, M., & Nomoto, A. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1302-1309.1989 · Cited by 232
NATHANSON, N., & MARTIN, J. R. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112848 · Cited by 214
Antigenic Structure of Picornaviruses
Minor, P. D. (1990) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-75602-3_5 · Cited by 187
Dual Stem Loops within the Poliovirus Internal Ribosomal Entry Site Control Neurovirulence
Gromeier, M., Bossert, B., Arita, M., Nomoto, A., & Wimmer, E. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.958-964.1999 · Cited by 160
Molecular epidemiology of polioviruses
Kew, O. M., Mulders, M. N., Lipskaya, G. Y., da Silva, E. E., & Patlansch, M. A. (1995) · Seminars in Virology · doi:10.1016/s1044-5773(05)80017-4 · Cited by 157
Self-citationDeterminants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine
Bouchard, M. J., Lam, D. H., & Racaniello, V. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4972-4978.1995 · Cited by 140
Comparative study of five methods for intratypic differentiation of polioviruses
van der Avoort, H. G., Hull, B. P., Hovi, T., Pallansch, M. A., Kew, O. M., Crainic, R., Wood, D. J., Mulders, M. N., & van Loon, A. M. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.10.2562-2566.1995 · Cited by 122
Self-citationMinor, P. D., & Dunn, G. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-5-1091 · Cited by 120
Research works printed but not linked: 5
- Andrus J. K., Strebel P. M., de Quadros C. A., Olive J. M., Bull. WHO 73, 33 (1995).
- Supplementary figures and details of experimental procedures are available on Science Online at www.sciencemag.org/cgi/content/full/1068284/DC1.
- Minor P. D., Curr. Top. Microbiol. Immunol. 161, 121 (1990).
- ___, Morb. Mortal. Wkly. Rep. 50, 41 (2001).
- Wood D. J., Sutter R. W., Dowdle W. R., Bull. WHO 78, 347 (2000).
Cited by
Items 301–400 of 594
Circulation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania
Combiescu, M., Guillot, S., Persu, A., Băicuş, A., Pițigoi, D., Balanant, J., Oprişan, G., Crainic, R., Delpeyroux, F., & Aubert-Combiescu, A. (2007) · Archives of Virology · doi:10.1007/s00705-006-0884-y · Cited by 19
“Dor=00) [28] and the Philippines (Sab1.”
BackgroundInfluentialPicornavirus Genetics: an Overview
Agol, V. I. (2014) · ASM Press eBooks · doi:10.1128/9781555817916.ch22 · Cited by 18
Gnanashanmugam, D., Halpern, M. S., Dodge, A., Fang, M., Wong, L. J., Esparza, M., Hammon, R. J., Rivas-Merelles, E. E., Santos, J. I., & Maldonado, Y. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02268-06 · Cited by 21
“Detection of OPV3 from vaccinees 11 weeks postvaccination implies its presence in the environment for sustained periods and the possibility of VAPP in poorly immunized communities, a common prerequisite for vaccinederived poliovirus (VDPV) outbreaks (12).”
BackgroundSobsey, M. D., & Pillai, S. D. (2009) · Journal of Water and Health · doi:10.2166/wh.2009.096 · Cited by 18
Limited and Localized Outbreak of Newly Emergent Type 2 Vaccine-Derived Poliovirus in Sichuan, China
Yan, D., Zhang, Y., Zhu, S., Chen, N., Li, X., Wang, D., Ma, X., Zhu, H., Tong, W., & Xu, W. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00196-14 · Cited by 17
“Apart from cVDPVs detected in China, which exhibited no recombination of Guizhou cVDPVs (35), and the vaccine/vaccine recombination of Sichuan cVDPVs reported here, all cVDPVs previously described underwent recombination with species C enteroviruses (cVDPVs identified in Egypt, Hispaniola, and the Philippines) (23, 33…”
ResultMolecular Basis of Genetic Variation of Viruses
Domingo, E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800837-9.00002-2 · Cited by 21
“Several recent poliomyelitis outbreaks have been associated with recombinants between oral poliovirus vaccine (OPV) viruses and other circulating enteroviruses (Gavrilin et al., 2000; Kew et al., 2002; Oberste et al., 2004).”
BackgroundSwitching from OPV to IPV: are we behind the schedule in Latin America?
Peraza, D. S., Avila-Aguero, M. L., & Morice, A. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.39 · Cited by 18
Wu, W., Xu, W., Chen, L., Chen, H., Liu, Q., Wang, D., Chen, Y., Yao, W., Li, G., Feng, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064889 · Cited by 17
“The first outbreak of poliomyelitis associated with VDPVs was reported in the Dominican Republic and Haiti from 2000 to 2001 [33].”
BackgroundDevaux, C. A., Pontarotti, P., Levasseur, A., Colson, P., & Raoult, D. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1284337 · Cited by 16
Virologic Surveillance for Wild-type Rubella Viruses in the Americas
Icenogle, J. P., Siqueira, M. M., Abernathy, E. S., Lemos, X. R. M. R., Fasce, R., Torres, G., & Reef, S. E. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir431 · Cited by 16
Clonality and intracellular polyploidy in virus evolution and pathogenesis
Perales, C., Moreno, E., & Domingo, E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501715112 · Cited by 16
Polio endgame: Lessons for the global rotavirus vaccination program
Jiang, B., Patel, M. M., & Glass, R. I. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.04.023 · Cited by 19
Altering Compositional Properties of Viral Genomes to Design Live-Attenuated Vaccines
Pereira-Gómez, M., Carrau, L., Fajardo, Á., Moreno, P., & Moratorio, G. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.676582 · Cited by 19
Hovi, T., Paananen, A., Blomqvist, S., Savolainen‐Kopra, C., Al‐Hello, H., Smura, T., Shimizu, H., Naďová, K., Sobotová, Z., Gavrilin, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066849 · Cited by 18
“circulate in the human population, lose their attenuation and cause paralytic poliomyelitis referred to as outbreaks due to circulating vaccine derived poliovirus (cVDPV), first of its kind discovered in 2000 in the island of Hispaniola [5,6].”
BackgroundSelf-citationManukyan, H., Zagorodnyaya, T. A., Rüttimann, R. W., Manor, Y., Bandyopadhyay, A. S., Shulman, L. M., Chumakov, K., & Laassri, M. (2018) · Journal of Virological Methods · doi:10.1016/j.jviromet.2018.06.009 · Cited by 16
Analysis of intermolecular RNA–RNA recombination by rubella virus
Adams, S. D., Tzeng, W., Chen, M. H., & Frey, T. K. (2003) · Virology · doi:10.1016/s0042-6822(03)00064-3 · Cited by 16
“Hahn et al., 1988; Kew et al., 2002) and among virus families (e.g., Zhang et al., 1992).”
BackgroundRomanenkova, N. I., Guillot, S., Rozaeva, N. R., Crainic, R., Bichurina, M. A., & Delpeyroux, F. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00017-06 · Cited by 16
“Nevertheless, four of the five poliomyelitis outbreaks involving VDPV were caused by strains resulting from recombination between an OPV strain and unidentified human enteroviruses, probably species C enteroviruses (18, 20, 31, 32, 39).”
BackgroundBoot, H. J., Kasteel, D., Buisman, A., & Kimman, T. G. (2003) · Journal of Virology · doi:10.1128/jvi.77.11.6541-6545.2003 · Cited by 16
Vaccination to protect against infection of the female reproductive tract
Huston, W. M., Harvie, M., Mittal, A. S., Timms, P., & Beagley, K. W. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.80 · Cited by 15
Polio eradication: where are we now?
Razum, O., & Müller, O. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62652-5 · Cited by 15
Toledano, M. (2021) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000930 · Cited by 19
Pralong, A., Levine, H. L., Lilja, J. E., Gaasvik, Å., & Hummel, H. (2014) · Engineering in Life Sciences · doi:10.1002/elsc.201400027 · Cited by 15
In Vitro Antiviral Activity of New Oxazoline Derivatives as Potent Poliovirus Inhibitors
Madia, V. N., Messore, A., Pescatori, L., Saccoliti, F., Tudino, V., Leo, A. D., Scipione, L., Fiore, L., Rhoden, E. E., Manetti, F., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01482 · Cited by 15
Self-citationTowards global poliomyelitis eradication: The successes and challenges for a developed country
Wood, N. J., & Thorley, B. R. (2003) · Journal of Paediatrics and Child Health · doi:10.1046/j.1440-1754.2003.00263.x · Cited by 16
Zhang, Y., Zhang, F., Zhu, S., Chen, L., Yan, D., Wang, D., Tang, R., Zhu, H., Hou, X., An, H., et al. (2009) · Archives of Virology · doi:10.1007/s00705-009-0564-9 · Cited by 15
“The biological role of the recombination of cVDPVs with the unidentified donor remains to be elucidated because this phenomenon has not appeared in all the cVDPVs that have been reported [26] and because the main determinants of attenuation of all three Sabin strains map to 50UTR and capsid region sites [4, 20, 41, 50…”
BackgroundInfluentialRecombinant Sabin environmental isolates in Greece and Cyprus
Paximadi, E., Karakasiliοtis, I., Papaventsis, D. C., Papageorgiou, G. T., & Markoulatos, P. (2007) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2007.03649.x · Cited by 20
“…occur mainly between Sabin strains (Cuervo et al. 2001; Georgopoulou and Markoulatos 2001; Blomqvist et al. 2003), but may also occur between Sabin and wild PV strains (Georgescu et al. 1995; Dahourou et al. 2002) or even between polio and non-polio EVs (Kew et al. 2002; Brown et al. 2003).”
BackgroundInfluentialKitamura, K., & Shimizu, H. (2021) · Viruses · doi:10.3390/v13071407 · Cited by 14
Self-citationCirculating vaccine derived polio virus type 1 outbreak, Saadah governorate, Yemen, 2020
Al-Qassimi, M. A., Amad, M. A. A., Anam, L., Almoayed, K. A., Al-Dar, A., & Ezzadeen, F. H. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07397-0 · Cited by 16
“The first documented cVDPV1 outbreak was in 2001, in Hispaniola [12].”
BackgroundDeterminants of monovalent oral polio vaccine mutagenesis in vaccinated elderly people
Boot, H. J., Sonsma, J. A. J., Nunen, F. J. H. B. V. A.-V., Abbink, F., Kimman, T. G., & Buisman, A. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.04.007 · Cited by 17
Polio vaccines and the eradication of poliomyelitis
Minor, P. D. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60921-0 · Cited by 14
Thompson, K. M., Kalkowska, D. A., & Badizadegan, K. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1891889 · Cited by 14
“paralytic cases caused by vaccine-derived polioviruses (VDPVs) [40,43,44].”
BackgroundTransmission dynamics of oral polio vaccine viruses and vaccine-derived polioviruses on networks
Kim, J., & Rho, S. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.09.026 · Cited by 14
Poliopolis: Pushing Boundaries of Scientific Innovations for Disease Eradication
Damme, P. V., Coster, I. D., Bandyopadhyay, A. S., Suykens, L., Rüdelsheim, P., Neels, P., Oberste, M. S., Weldon, W. C., Clemens, R. L., & Revets, H. (2019) · Future Microbiology · doi:10.2217/fmb-2019-0196 · Cited by 15
Self-citationUniversal use of inactivated polio vaccine
Carvalho, L. H. F., & Weckx, L. Y. (2006) · Jornal de Pediatria · doi:10.2223/jped.1493 · Cited by 17
Field Epidemiology and Laboratory Training Program, Where Is the L-Track?
Gatei, W., Galgalo, T., Abade, A., Henderson, A. K., Rayfield, M. A., McAlister, D., Montgomery, J. M., Peruski, L. F., & Albetkova, A. A. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00264 · Cited by 14
“Significant global health security contributions by the graduates of the FETPs included detection of vaccine-type poliovirus in Dominican Republic and Haiti in 1991, Escherichia coli O157:H7 in Germany and measles outbreaks in Thailand among others (1, 2).”
BackgroundHealth economic analysis of vaccine options for the polio eradication endgame: 2022-2036
Thompson, K. M., Kalkowska, D. A., & Badizadegan, K. (2022) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2128108 · Cited by 13
“Successful eradication of the transmission of wild polioviruses (WPVs) represents a first step in achieving the global goal of ending all cases of poliomyelitis.”
InfluentialWang, H.-B., Fang, G., Yu, W., Du, F., Fan, C., Liu, Q., Hao, L., Liu, Y., Zheng, J., Qin, Z.-Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113880 · Cited by 13
“sanitation and tropical or subtropical climates [15], however, the key risk factor for cVDPVs emergence and spread is low population immunity [14, 16].”
BackgroundConsiderations in the design of vaccines that induce CD8 T cell mediated immunity
Zaiss, D. M. W., Boog, C. J. P., van Eden, W., & Sijts, A. J. A. M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.101 · Cited by 15
“One prominent example is the oral olio vaccine (Sabin vaccine), which has been widely replaced by vaccine based on inactivated polio virus (Salk vaccine), due to requent episodes of spontaneous recombinations and outbreaks f infections linked to vaccination campaigns [90].”
BackgroundLi, R., Li, C., Wang, H., Luo, H., Li, Y., Wang, J., Ying, Z., Yu, W., Shu, J. D., Wen, N., et al. (2015) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piv017 · Cited by 13
“[12].”
McDonald, S. L., Weldon, W. C., Wei, L., Chen, Q., Shaw, J., Zhao, K., Jorba, J. C., Kew, O. M., Pallansch, M. A., Burns, C. C., et al. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.02.035 · Cited by 14
Self-citationAnno 2021: Which antivirals for the coming decade?
Groaz, E., Clercq, E. D., & Herdewijn, P. A. (2021) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2021.09.004 · Cited by 19
“These variants are genetically distinct from wild polioviruses but cannot be distinguished in terms of pathogenicity and transmissibility.(169) At present, cVDPVs, particularly strains of serotype 2, are responsible for the majority of paralytic polio outbreaks worldwide.”
BackgroundTohme, R. A., François, J., Cavallaro, K. F., Paluku, G. K., Yalcouyé, I., Jackson, E., Wright, T., Adrien, P., Katz, M. A., Hyde, T. B., et al. (2017) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0802 · Cited by 15
“Haiti was given particular consideration for ES for VDPVs because of 1) long history of suboptimal polio vaccination coverage, 2) poor sanitary conditions, 3) high level of population movement and high numbers of international visitors, and 4) history of a cVDPV1 outbreak during 2000–2001.(19,21,39) In 2016, ES was es…”
BackgroundInfluentialEnteroviruses and Parechoviruses
Pallansch, M. A., & Oberste, M. S. (2009) · Wiley eBooks · doi:10.1128/9781555815974.ch18 · Cited by 13
Self-citationSabin Strain Inactivated Polio Vaccine for the Polio Endgame
Modlin, J. F., & Chumakov, K. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz077 · Cited by 13
Emergence of Vaccine-Derived Polioviruses during Ebola Virus Disease Outbreak, Guinea, 2014–2015
Fernández-García, M. D., Majumdar, M., Kébé, O., Fall, A. D., Kone, M., Kande, M., Dabo, M., Sylla, M. S., Sompare, D., Howard, W., et al. (2017) · Emerging infectious diseases · doi:10.3201/eid2401.171174 · Cited by 14
“The first known outbreak of cVDPV infection was reported in Hispaniola in 2000–2001 (4), although retrospective analyses of poliovirus isolates from Egypt during the 1960s suggest that this phenomenon might have been more common than anticipated.”
BackgroundKim, H.-J., Aponte-Diaz, D., Sotoudegan, M. S., Shengjuler, D., Arnold, J. J., & Cameron, C. E. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3001693 · Cited by 13
“…: Pleaseverifythatallentriesarecorrect : second epidemiological challenge produced by RNA recombination is the creation of virulent, vaccine-derived poliovi-ruses (PVs) by recombination of live, attenuated vaccine strains with circulating, wild species-C enteroviruses [9].”
Polio Eradication: Interrupting Transmission, Towards a Polio-Free World
Heymann, D. L., Sutter, R. W., & Aylward, R. B. (2006) · Future Virology · doi:10.2217/17460794.1.2.181 · Cited by 12
“Vaccine-derived polioviruses Since the late 1990s, it has been recognized that polio outbreaks can be caused by cVDPVs; by late-2005, six outbreaks arising from Sabinderived poliovirus strains had been documented in Hispaniola (2000–2001), the Philippines (2001), Madagascar (2002 and 2005), China (2004) and Indonesia…”
BackgroundSelf-citationKurosawa, Y., Sato, S., Okuyama, T., & Taoka, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222199 · Cited by 12
“The Sabin oral vaccine causes occasional incidences of vaccine-associated paralytic poliomyelitis by a circulating vaccine-derived poliovirus [20]; hence, the development of a noninfectious method of vaccination has become a priority.”
BackgroundDetection of viral sequences in archival spinal cords from fatal cases of poliomyelitis in 1951–1952
Rekand, T., Male, R., Myking, A. O., Nygaard, S. J. T., Aarli, J. A., Haarr, L., & Langeland, N. (2003) · Journal of Virological Methods · doi:10.1016/j.jviromet.2003.08.013 · Cited by 12
Tafuri, S., Prato, R., Martinelli, D., Calvario, A., Bozzi, A., Labianca, M., Patti, A., Lopalco, P. L., & Germinario, C. A. (2008) · BMC Infectious Diseases · doi:10.1186/1471-2334-8-150 · Cited by 12
Evolution of Newly Described Enteroviruses
Smura, T., Savolainen‐Kopra, C., & Roivainen, M. (2010) · Future Virology · doi:10.2217/fvl.10.62 · Cited by 13
Kinder- und Jugendgesundheitssurvey (KiGGS): Immunitätslage gegen Poliomyelitis
Diedrich, S., & Schreier, E. (2007) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-007-0239-1 · Cited by 20
Error Frequencies of Picornavirus RNA Polymerases: Evolutionary Implications for Virus Populations
Domingo, E., Baranowski, É., Escarmís, C., Sobrino, F., & Holland, J. J. (2014) · ASM Press eBooks · doi:10.1128/9781555817916.ch23 · Cited by 13
The Mechanism of Poliovirus Eradication
Kew, O. M., & Pallansch, M. A. (2014) · Molecular Biology of Picornavirus · doi:10.1128/9781555817916.ch39 · Cited by 12
Self-citationDelpeyroux, F., Colbère-Garapin, F., Razafindratsimandresy, R., Sadeuh-Mba, S., Joffret, M.-L., Rousset, D., & Blondel, B. (2013) · médecine/sciences · doi:10.1051/medsci/20132911021 · Cited by 11
“Les deux premières ont été causées par des virus de type 1 sur l’île d’Hispaniola (à Saint Domingue et Haïti) et aux Philippines [7, 8].”
A Risk Management Approach to Global Pandemics of Infectious Disease and Anti-Microbial Resistance
Sparrow, A., Smith-Torino, M., Shamamba, S., Chirakarhula, B., Lwaboshi, M., Benn, C. S., & Chumakov, K. (2024) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed9110280 · Cited by 11
“Vaccine-derived polio strains pose an equally significant threat because their virulence is indistinguishable from wild strains, and both forms of the virus can cause outbreaks of paralytic polio [17].”
Epidemiology of viral encephalitis
Khetsuriani, N., & Anderson, L. J. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511541728.022 · Cited by 11
Sharif, S., Abbasi, B. H., Khurshid, A., Alam, M. M., Shaukat, S., Angez, M., Rana, M. S., & Zaidi, S. S. Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088442 · Cited by 12
“The second type, cVDPVs, arises as a result of sustained person to person transmission within an inadequately immunized population and first outbreak of these VDPVs was reported from Hispaniola (Haiti and the Dominican Republic) in 2001 [11].”
BackgroundA neonatal murine model for evaluation of enterovirus E HY12 virus infection and pathogenicity
Gai, X., Zhang, Q., Lu, H., Yang, Z., Zhu, L., Li, X., & Wang, X. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193155 · Cited by 11
Chen, H., Gao, Z., Bai, S., Liu, X., Han, S., Xiao, Y., Liu, F., Yu, Y., Sun, H., & Yang, X. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.02.073 · Cited by 11
Kunec, D., Osterrieder, N., & Trimpert, J. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.08.027 · Cited by 11
“This risk particularly exists when only a few nucleotide changes are responsible for the attenuation, as was the case with the oral poliovirus vaccine [20].”
Kalkowska, D. A., Wassilak, S. G. F., Wiesen, E., Estívariz, C. F., Burns, C. C., Badizadegan, K., & Thompson, K. M. (2023) · Gates Open Research · doi:10.12688/gatesopenres.14511.1 · Cited by 12
Self-citation[Epidemiology of enterovirus associated with neurologic diseases].
Cisterna, D. M., Palacios, G. F., Rivero, K. A., Girard, D., Lema, C. L., & Freire, M. C. (2007) · Medicina-buenos Aires · Cited by 13
Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria
Giwa, F. J., Olayinka, A., & Ogunsola, F. T. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.05.198 · Cited by 11
Immunizations, Vaccine-Preventable Diseases, and HIV Infection
Nakashima, A. K., & Onorato, I. M. (2004) · Elsevier eBooks · doi:10.1016/b978-012764051-8/50040-8 · Cited by 11
Enterovirus and Parechovirus Infections
Cherry, J. D., & Krogstad, P. A. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6400-8.00024-9 · Cited by 13
Introduction to the Human Enteroviruses and Parechoviruses
Romero, J. R., & Modlin, J. F. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00172-7 · Cited by 13
Virus Evolution in Prolonged Infections of Immunocompromised Individuals
Raglow, Z., & Lauring, A. S. (2024) · Clinical Chemistry · doi:10.1093/clinchem/hvae150 · Cited by 13
Poliovirus Containment Risks and Their Management
Tebbens, R. J. D., Kalkowsa, D. A., & Thompson, K. M. (2018) · Future Virology · doi:10.2217/fvl-2018-0079 · Cited by 10
ENTEROVIRUSES AND PARECHOVIRUSES
Cherry, J. D., & Krogstad, P. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50183-7 · Cited by 11
Trueba, G. A., Jeyaseelan, V., López, L., Mainou, B. A., Zhang, Y., Whittembury, Á., Valarezo, A. J. O., Baquero, G., de Aguinaga, R. R., Salinas, L. J. Z., et al. (2021) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100235 · Cited by 11
Genetic features of polioviruses isolated in Tunisia, 1991–2006
Boubaker, S., Yahia, A. B., Bahri, O., Morel, V., Balanant, J., Delpeyroux, F., & Triki, H. (2007) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.10.002 · Cited by 10
Poliovirus Studies during the Endgame of the Polio Eradication Program
Arita, M. (2016) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2016.356 · Cited by 13
“Enumerating all of the milestones reached in PV studies is far beyond the scope of this review, however, this list would include sequencing of the PV genome (9,10), the development of reverse genetics for the virus (11), elucidation of the crystal structure of the virion (12), identification of the internal ribosomal…”
BackgroundAlleman, M. M., Coulliette-Salmond, A. D., Pierre, W., Belgasmi, H., Sayyad, L., Wong, K., Gue, E., Barrais, R., Rey-Benito, G. J., Burns, C. C., et al. (2021) · Viruses · doi:10.3390/v13030505 · Cited by 14
“These four cities were chosen because they are among the most populated in the country with road accessibility throughout the rainy and dry seasons, are in regions involved in the 2000–2001 cVDPV1 outbreak, and have open canals that make sample collection feasible [17–19 ,22, 23].”
Self-citationUniversal immunization program and polio eradication in India.
Vashishtha, V. M., John, T. J., Agarwal, R. K., & Kalra, A. (2008) · PubMed · Cited by 10
Global trends in poliomyelitis research over the past 20 years: A bibliometric analysis
Liu, Q., Liu, Z., Huang, B.-L., Teng, Y., Li, M., Peng, S., Guo, H., Wang, M., Liang, J., & Zhang, Y. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2173905 · Cited by 10
“Their paper described a poliomyelitis outbreak in Hispaniola, which was associated with circulating type 1 vaccine-derived poliovirus.(35) In addition, the study conducted by Kew, OM et al.”
BackgroundOutbreak management strategies for cocirculation of multiple poliovirus types
Kalkowska, D. A., Badizadegan, K., & Thompson, K. M. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.04.037 · Cited by 10
Pliaka, V., Dedepsidis, E., Kyriakopoulou, Z., Mpirli, K., Tsakogiannis, D., Pratti, A., Levidiotou-Stefanou, S., & Markoulatos, P. (2009) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2009.11.003 · Cited by 16
“Intertypic recombination usually occurs in the nonstructural protein genome region [5,15,16] while only three reports indicated recombination in the 30 end of VP1 genomic region [17e19] leading to a chimeric S3/S2 VP1 capsid protein.”
BackgroundAdu, F., Iber, J. C., Harry, T. O., Burns, C. C., Oyedele, O. I., Adeniji, J. A., Mubarak, O. T., & Kew, O. M. (2003) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb2003.000-1092 · Cited by 10
“Again this is consistent with earlier findings of other workers who observed that crossovers are most common in the noncapsid region than in the untranslated and capsid regions (Kew et al., 2002, Martin et al., 2000).”
ResultSelf-citationAttenuation of Viruses by Large-Scale Recoding of their Genomes: the Selection Is Always Biased
Osterrieder, N., & Kunec, D. (2018) · Current Clinical Microbiology Reports · doi:10.1007/s40588-018-0080-3 · Cited by 13
Bolanaki, E., Kottaridi, C., Markoulatos, P., Margaritis, L. H., & Katsorchis, T. (2006) · Virus Genes · doi:10.1007/s11262-005-6909-x · Cited by 16
Vaccine derived bi- and multi-recombinant Sabin strains
Paximadi, E., Karakasiliοtis, I., Bolanaki, E., Krikelis, A., & Markoulatos, P. (2007) · Virus Genes · doi:10.1007/s11262-007-0146-4 · Cited by 13
Kohler, K. A., Hlady, W. G., Banerjee, K., & Sutter, R. W. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg011 · Cited by 10
Self-citationThe Demise and Rebirth of Polio—A Modern Phoenix?
Wright, P. F., & Modlin, J. F. (2008) · The Journal of Infectious Diseases · doi:10.1086/525050 · Cited by 10
Thorley, B. R., Brussen, K. A., Stambos, V., Yuen, L. K. W., & Kelly, H. A. (2002) · Communicable Diseases Intelligence · doi:10.33321/cdi.2002.26.34 · Cited by 10
The Long and Winding Road to Eradicate Vaccine-Related Polioviruses
Cochi, S. L., & Pallansch, M. A. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa393 · Cited by 9
Self-citationThe respiratory route of transmission of virulent polioviruses
John, T. J., Dharmapalan, D., Steinglass, R., & Hirschhorn, N. (2024) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2024.2392791 · Cited by 9
“The emergence of cVDPV is essentially a twenty first century phenomenon [31].”
Vaccine-associated Paralytic Poliomyelitis Caused by Contact Infection
Okuda, B., Uetani, E., & Okamoto, K. (2006) · Internal Medicine · doi:10.2169/internalmedicine.45.1622 · Cited by 9
“On the other hand, outbreaks of AAP have been reported in this century to be associated with circulating vaccine-derived poliovirus or its recombinant strains in tropical developing countries (8, 9).”
BackgroundThe probability of undetected wild poliovirus circulation: Can we do better?
Houy, N. (2015) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2015.06.046 · Cited by 9
A Transgenic Mouse Model of Poliomyelitis
Koike, S., & Nagata, N. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3292-4_7 · Cited by 9
Circulating vaccine derived poliovirus and the polio eradication endgame.
Davis, R., & Wright, P. F. (2012) · PubMed Central · Cited by 9
The Role of Mathematical Models in Vaccine Development and Public Health Decision Making
Boily, M., Brisson, M., Mâsse, B. R., & Anderson, R. M. (2012) · Wiley eBooks · doi:10.1002/9781118345313.ch32 · Cited by 9
Polio vaccines and the cessation of vaccination
Minor, P. D. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.1.99 · Cited by 9
Friedrichs, V., Calvelage, S., Holzum, T., Viaplana, E., Urniza, A., Balasch, M., Beer, M., Blome, S., & Schäfer, A. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1823118 · Cited by 8
“Additionally, emergence and spread of mutated LAVs might disrupt the success of mass vaccine campaigns, as observed for polio (Kew et al., 2002; Kew et al., 2005; Stern et al., 2017).”
Liu, Y., Ma, T., Liu, J., Zhao, X., Cheng, Z., Guo, H., Xu, R., & Wang, S. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2014.979147 · Cited by 9
“For example, circulating type 1 vaccinederived poliovirus (VDPV) is a highly pathogenic poliovirus that has evolved from an avirulent strain [9].”
BackgroundZaman, K., Kovacs, S., VanderEnde, K. E., Aziz, A. B., Yunus, M., Khan, S., Snider, C. J., An, Q., Estívariz, C. F., Oberste, M. S., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.08.065 · Cited by 8
Self-citationEl-Sayed, Z. F., & Mach, O. (2016) · Journal of Vaccines & Vaccination · doi:10.4172/2157-7560.1000331 · Cited by 8
“In addition, through prolonged replication in a single immunodeficient host or serial transmission in an under-vaccinated community these attenuated polioviruses can evolve and regain the neurovirulence and transmission characteristics of wild poliovirus [3,4].”
BackgroundArbo, A., Falleiros-Arlant, L. H., López, E. L., del Castillo, J. B., de Cuéllar, C. M., Moreno, G., Rolón, R., Cerda, J., & Eguiazú, S. (2018) · Revista chilena de infectología · doi:10.4067/s0716-10182018000400395 · Cited by 8
Kew, O. M. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7448-8_13 · Cited by 9
Self-citationSullivan, K. E., Bassiri, H., Bousfiha, A. A., Costa‐Carvalho, B. T., Freeman, A. F., Hagin, D., Lau, Y., Lionakis, M. S., Moreira, I., Pinto, J. A., et al. (2017) · Journal of Clinical Immunology · doi:10.1007/s10875-017-0426-2 · Cited by 11
“An example for such an event was demonstrated by the 2000–2001 outbreak in the Dominican Republic and Haiti [247], believed to be driven at least in part by undervaccination of the population, which allowed the spread of the reverted vaccine strain [248].”
Background
Metadata
- Authors
- Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., Sutter, R., Tambini, G., Venczel, L., Pedreira, C., Laender, F., Shimizu, H., Yoneyama, T., Miyamura, T., van der Avoort, H., Oberste, M. S., Kilpatrick, D., Cochi, S., Pallansch, M., & de Quadros, C.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Caribbean Epidemiology Centre (CAREC) Laboratory, Pan American Health Organization (PAHO), 16-18 Jamaica Boulevard, Federation Park, Port-of-Spain, Trinidad and Tobago.
- World Health Organization Regional Office for the Americas (US)
- Ministry of Health, Avenida San Cristóbal esquina Tiradentes, Santo Domingo, Dominican Republic.
- Ministry of Public Health, Port-au-Prince, Haiti.
- PAHO, Calle Pepillo Salcedo, Plaza de la Salud, Santo Domingo, Dominican Republic.
- PAHO, Number 295 Avenue John Brown, Port-au-Prince, Haiti.
- National Institute of Infectious Diseases (JP)
- Polio Laboratory, National Institute of Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3720 BA, Bilthoven, Netherlands.
- Division of Vaccines and Immunization, PAHO, 525 Twenty-Third Street, N.W., Washington, DC 20037, USA.
- Corresponding author
- Kew, Olen
- ORCID
- Venue
- Science
- Published
- 2002-04-12
- Volume
- 296
- Issue
- 5566
- Pages
- 356-359
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2101037145
- Cited by
- 600
- References
- 19
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 15 · 2023: 19 · 2022: 20 · 2021: 15 · 2020: 17 · 2019: 17 · 2018: 21 · 2017: 21 · 2016: 26 · 2015: 22 · 2014: 39 · 2013: 26 · 2012: 26
- FWCI
- 25.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- poliomyelitis outbreak, vaccine-derived poliovirus, poliovirus type 1, oral polio vaccine, Hispaniola, Dominican Republic, Haiti, unvaccinated children, low vaccination coverage, paralytic poliomyelitis, wild poliovirus
- MeSH terms
- Adolescent, Animals, Capsid, Child, Child, Preschool, Disease Outbreaks, Dominican Republic, Female, Genes, Viral, Haiti, Humans, Infant, Male, Molecular Sequence Data, Poliomyelitis, Poliovirus Vaccine, Oral, Population Surveillance, Recombination, Genetic, Vaccination, Virulence, Point Mutation, Immunization Programs, Poliovirus, 5' Untranslated Regions, Capsid Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.